CBT Stock: Price, Earnings History and SEC Filings
Cabot Corporation (CBT) last traded at $74.43, up 0.79% on the latest session and down 3.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.67 against an analyst estimate of $1.66, a beat of 0.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CBT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $1.67 | $1.66 | +0.60% |
| Mar 2026 | May 5, 2026 | $1.61 | $1.47 | +9.52% |
| Dec 2025 | Feb 3, 2026 | $1.53 | $1.40 | +9.29% |
| Sep 2025 | Nov 3, 2025 | $1.70 | $1.72 | -1.16% |
CBT beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How CBT reacts to earnings
Across its last 8 earnings releases, CBT moved 6.3% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-03 | After close | -8.51% |
| 2026-05-05 | After close | +4.41% |
| 2026-02-03 | After close | +10.44% |
| 2025-11-03 | After close | -7.07% |
| 2025-08-04 | After close | +8.67% |
| 2025-05-05 | After close | -6.49% |
| 2025-02-03 | After close | +3.91% |
| 2024-11-04 | After close | -1.12% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
CBT financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $3.7B | $331M | $391M | 8.9% | $6.02 |
| 2024 | $4.0B | $380M | $451M | 9.5% | $6.72 |
| 2023 | $3.9B | $445M | $351M | 11.3% | $7.73 |
| 2022 | $4.3B | $209M | -$111M | 4.8% | $3.62 |
| 2021 | $3.4B | $250M | $62M | 7.3% | $4.34 |
| 2020 | $2.6B | -$238M | $177M | -9.1% | $-4.21 |
| 2019 | $3.3B | $157M | $139M | 4.7% | $2.63 |
| 2018 | $3.2B | -$113M | $69M | -3.5% | $-1.85 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CBT
- 8-K · Sep 15, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 21, 2026Other events, Financial statements and exhibits
- 424B2 · Aug 14, 2026
- 8-K · Aug 14, 2026Other events, Financial statements and exhibits
- 424B2 · Aug 12, 2026
- 10-Q · Aug 4, 2026
- 8-K · Aug 3, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 30, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 14, 2026Material agreement, Agreement terminated, New financial obligation
- 10-Q · May 6, 2026
Insider filing activity
CBT insiders filed 15 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
CBT news
- Cabot CorpOct 30, 2026 · 247wallst.com
- 3 Dividend Stocks To Own In October 2026Oct 23, 2026 · finance.yahoo.com
- NEM Q3 Earnings Beat Estimates on Higher Gold Prices, Strong SalesOct 23, 2026 · finance.yahoo.com
- DuPont Expands Bioprocessing Portfolio With New Chromatography MediaOct 23, 2026 · finance.yahoo.com
- DOW Q3 Earnings Beat Estimates on Pricing Gains and Cost ActionsOct 22, 2026 · finance.yahoo.com
- Nucor Expands Towers & Structures Capacity to Meet Rising DemandOct 22, 2026 · finance.yahoo.com
- Is Cabot (CBT) Stock Outpacing Its Basic Materials Peers This Year?Oct 21, 2026 · finance.yahoo.com
About Cabot Corporation
Cabot Corporation (CBT) is a US-listed public company on NYSE. The SEC classifies its business as Miscellaneous Chemical Products. It is incorporated in DE. Its fiscal year ends in September.